The NHS has been hailed as a pioneer in harnessing the power of technology to improve patient care. But a recent intervention from the UK's statistics watchdog serves as a timely reminder that claims about its effectiveness must be treated with caution. When it comes to evaluating the impact of new software like Palantir, the line between correlation and causation can be perilously thin.
The regulator has issued guidance urging NHS organisations to be more precise in their language when presenting 'before and after' comparisons. This is a crucial distinction: just because certain metrics improve after implementing technology doesn't necessarily mean it's the direct cause of those improvements. In fact, a multitude of factors could be at play – from changes in staffing levels to shifts in patient demand.
The Palantir Foundry platform, which is being rolled out across various NHS trusts, promises to integrate and analyse vast amounts of patient data, improving operational efficiency, patient flow, and resource allocation. But while proponents argue it can help identify bottlenecks and predict demand spikes, the exact mechanisms and extent of its direct impact require rigorous, controlled evaluation.
For instance, if a hospital's waiting lists decrease after Palantir's implementation, it could be due to factors other than the software itself – such as increased staffing or new clinical pathways. The statistics watchdog's guidance serves as a reminder that robust statistical methods are needed to isolate the specific effect of the software from other contributing variables.
This directive aligns with principles of transparent government communication and responsible data use in public services. As NICE advises, interventions must be supported by clear, verifiable data demonstrating genuine efficacy rather than mere association.